Discover, explore & compare companies within the Healthcare Sector from the London Stock Exchange (LSE). Download the latest price data & trading signals

Indivior currently has positive PPO 2.600
Percentage Price /
Indivior currently has positive PPO 2.600

[BULLISH CROSSOVER]: Indivior currently has positive PPO 2.600%. This means the current price is gaining momentum through a rise on the short term exponential moving average.

The 161.8% Fibonacci extension level for HIK has moved to the lower limit. Stoploss should be positioned @$1564.68
Fibonacci Extensions /
The 161.8% Fibonacci extension level for HIK has moved to the lower limit. Stoploss should be positioned @$1564.68

Hikma Pharmaceuticals has moved below the 161.8% level ($1482.68) [Bullish]. Look for a long limit order entry near this point. Exit price for HIK should be set @$1400.68 & Stoploss for Hikma Pharmaceuticals should be set at $1564.68

Low Price /
Cambian : Daily low price is $175.25 [Lower low]

[BULLISH]: Cambian current downtrend in the first timeframe. Currently, the Low is $175.25 (-4.2 %).

Moving Average Envelope /
[NEUTRAL]: Shire current trading has closed out Envelope Bands to oversold status

[NEUTRAL]: Shire current trading has closed out Envelope Bands to oversold status and signalled the initiation of normal trading conditions. Currently, the Lower Band is 3486.0535.

Moving Average Envelope /
Hikma Pharmaceuticals: Closing price $1102 is below the Lower Envelope Band ($1029.4485)

[BULLISH]: Hikma Pharmaceuticals current trading has maintained the Envelope Bands to oversold status and signalled the continuation of the bullish trading conditions. Currently, the Lower Band is 1029.4485.

Medium Trend /
[Downtrend]: The second timeframe trend has been confirmed for GSK

[BEARISH]: Glaxosmithkline has a medium timeframe downtrend confirmation. This was confirmed through a price breakout on the Nov 9 2017.

Top companies for
London Stock Exchange
Advertisment
Camarilla Pivot Points /
Limit order for a short position has been identified for Cambian [Bearish]

Cambian has broken the first Camarilla support point ($167.444) [Bearish]. Look for a short limit order entry near this point. Exit price for CMBN should be set @$152.389 & short position stoploss for Cambian should be set between $212.611 & $227.667

[Short]: Exit price for INDV should be set @$373.25
Demarks Pivot Points /
[Short]: Exit price for INDV should be set @$373.25

Indivior has broken the first DeMark support point ($376.125) [Bearish]. Look for a short limit order entry near this point. Exit price for INDV should be set @$373.25 & short position stoploss for Indivior should be set at $377.55

Indivior is no longer oversold [Neutral]
Moving Average Envelope /
Indivior is no longer oversold [Neutral]

[NEUTRAL]: Indivior current trading has closed out Envelope Bands to oversold status and signalled the initiation of normal trading conditions. Currently, the Lower Band is 346.4650.

Triangular Moving Average /
Shire: Closing price $3579 is above the TMA(5) @$3563.58

[BULLISH]: Shire currently has a confirmed uptrend. Recent trading has caused the TMA 5 day average to exceed the closing price confirming the short term trend following indicator. Currently, the return on TMA5 is -2.7%.

Moving Average Envelope /
NMC Health is no longer oversold and normal trading conditions are resumed

[BEARISH]: NMC Health current trading has maintained the Envelope Bands to overbought status and signalled the continuation of the bearish trading conditions. Currently, the Upper Band is 3002.8530.

High Price /
[Bearish]: Genus has failed beat previous high by -1.3 %

GNS: HIGH Current Signal -> (1) 20 Nov: BEARISH (2) 17 Nov: BEARISH (3) 16 Nov: BEARISH

Daily trading has confirmed an Aroon uptrend (40) for Advanced Medical Solutions
Aroon Oscillator /
Daily trading has confirmed an Aroon uptrend (40) for Advanced Medical Solutions

[BULLISH]: Advanced Medical Solutions has a current ARO(25) of 40. This has change 56 points from yesterday.

Price is now trading below the Weighted Moving Average(5) for SN
Weighted Moving Average /
Price is now trading below the Weighted Moving Average(5) for SN

[BEARISH]: Smith & Nephew currently has a confirmed downtrend. Recent trading has caused the WMA 5 day average to move below the closing price confirming the short term trend following indicator. Currently, the return on WMA5 is -0.4%.

Ulcer Index /
Ulcer index has increased as the price has fallen for Hikma Pharmaceuticals

[BULLISH]: Hikma Pharmaceuticals UIX index implies that the downside risk of the current trading price is high. Currently, the UIX is 12.61.

Average True Range /
Glaxosmithkline has signalled an ATR trend present [Uptrend]

[Bullish]: Average True Range has confirmed an uptrend is present. Glaxosmithkline has a TR of 10.098, and an ATR(14) of 23.626.

Triangular Moving Average /
TMA(15) is now trading above the TMA(30) for Genus

[BEARISH]: Genus currently has a confirmed downtrend. Recent trading has caused the TMA 5 day average to move below the closing price confirming the short term trend following indicator. Currently, the return on TMA5 is 0.4%.

Indivior: Current trading activity signals DVI distribution is present
Daily Volume Index /
Indivior: Current trading activity signals DVI distribution is present

[BEARISH]: Indivior current distribution has given weakness to the share price and the continuation of bearish trading conditions.

William %R Oversold signal is still current for Genus [Bullish]
Williams %R /
William %R Oversold signal is still current for Genus [Bullish]

[BEARISH]: Genus is currently Overbought highlighting the potential for a short term trend reversal in the downward direction.

[Bear Power]: ERI has increased for Glaxosmithkline during the last trading session
Elder Ray Index /
[Bear Power]: ERI has increased for Glaxosmithkline during the last trading session

[BEARISH]: GlaxosmithklineElder Ray Index is signalling a Bearish movementERI is -25.878 indicating bear power. Prices are being driven below the consensus of value for GSK during the last trading session [Selling Pressure]

Closing Price /
Recent trading for Astrazeneca fell short of the previous close by -0.1 %

[BEARISH]: Astrazeneca current downtrend in the first timeframe. Currently, the Close is $4960.5.

Percentage Volume /
Volume for Glaxosmithkline is now losing momentum @-4.8)

[BEARISH CROSSOVER]: Glaxosmithkline currently has negative PVO -4.8%. The recent volume is losing momentum through a fall on the short term exponential moving average. Currently, the return on PVO is 0.5%.

Camarilla Pivot Points /
Abcam has broken the first Camarilla support point ($899) [Bearish]

Abcam has broken the first Camarilla support point ($899) [Bearish]. Look for a short limit order entry near this point. Exit price for ABC should be set @$817.5 & short position stoploss for Abcam should be set between $1143.5 & $1225

Genus has broken the first Woodie resistance point ($2211.5) [Bullish]
Woodie Pivot Point /
Genus has broken the first Woodie resistance point ($2211.5) [Bullish]

Genus has broken the first Woodie resistance point ($2211.5) [Bullish]. Look for a long limit order entry near this point. Exit price for GNS should be set @$2221.75 & Stoploss for Genus should be set at $2175.75

NMC Health: Daily closing price is $2730 [Bullish]
Closing Price /
NMC Health: Daily closing price is $2730 [Bullish]

[BULLISH]: NMC Health current uptrend in the first timeframe. Currently, the Close is $2730.

Demarks Pivot Points /
Clinigen has moved above the R1 DeMark pivot point ($993.5) [Bullish]

Clinigen has broken the first DeMark resistance point ($993.5) [Bullish]. Look for a long limit order entry near this point. Exit price for CLIN should be set @$1021 & Stoploss for Clinigen should be set at $979

See More   See more results
Advertisment
Advertisment
back to top